Korean Lab Study Finds COVID-19 mRNA Vaccines May Pose Cardiac Threat for Persons with Chronic Inflammation

South Korean researchers affiliated with Jungwon University, The Catholic University of Korea and Samsung Medical Center raise safety questions about mRNA COVID-19 vaccines. Specifically, these novel products accelerated during a time of global public health emergency used snippets of genetic material to trigger an immune response in the body against COVID-19. Yet this process that can potentially set off adverse reactions is not as well understood in persons with chronic inflammatory conditions. While vaccination routes remain questionable.  Establishing a mouse model in the laboratory, the researchers studied the effects of mRNA vaccines with an emphasis of their cardiac toxicity and immunogenicity dependent on the injection route.

The recent results, raising concern, are in PLOS One.  The recent study was made possible by funding from the Korea Ministry of Food and Drug Safety, the Korea Health Industry Development Institute (KHIDI) via the Ministry of Health & Welfare, Republic of Korea.